Hap Trading, LLC Horizon Therapeutics Public LTD CO Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $831,715 - $1.22 Million	10,475 New	10,475 $835,000
Q2 2021 Aug 11, 2021	SELL	$86.24 - $95.92 $2.03 Million - $2.26 Million	-23,562 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $6.83 Million - $9.08 Million	-95,055 Reduced 80.14%	23,562 $2.17 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $7.95 Million - $10 Million	118,617 New	118,617 $8.68 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.